Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

PHXM | PHAXIAM Therapeutics S.A. ADR

Index- P/E- EPS (ttm)-0.10 Insider Own6.35% Shs Outstand6.07M Perf Week4.97%
Market Cap31.50M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float5.69M Perf Month-4.44%
Income-0.31M PEG- EPS next Q-3.53 Inst Own0.22% Short Float / Ratio0.35% / 1.09 Perf Quarter-34.30%
Sales0.00M P/S- EPS this Y- Inst Trans- Short Interest0.02M Perf Half Y-43.58%
Book/sh8.08 P/B0.64 EPS next Y- ROA-0.50% Target Price37.02 Perf Year-13.64%
Cash/sh6.82 P/C0.76 EPS next 5Y- ROE-1.22% 52W Range3.00 - 14.00 Perf YTD57.23%
Dividend- P/FCF- EPS past 5Y70.34% ROI-0.87% 52W High-62.93% Beta2.54
Dividend %- Quick Ratio3.65 Sales past 5Y0.00% Gross Margin- 52W Low73.00% ATR0.72
Employees49 Current Ratio3.65 Sales Q/Q- Oper. Margin0.00% RSI (14)52.19 Volatility11.77% 15.14%
OptionableNo Debt/Eq0.58 EPS Q/Q- Profit Margin- Rel Volume1.39 Prev Close4.74
ShortableYes LT Debt/Eq0.43 Earnings- Payout- Avg Volume18.32K Price5.19
Recom4.00 SMA208.80% SMA50-1.44% SMA200-27.32% Volume25,475 Change9.49%
Jun-28-23 04:05PM
Jun-27-23 12:00PM
Jun-26-23 04:05PM
Jun-23-23 04:30PM
Jun-20-23 04:05PM
02:00PM Loading…
Jun-14-23 02:00PM
Jun-13-23 12:00PM
Jun-12-23 01:00AM
Jun-05-23 02:00AM
May-24-23 04:05PM
May-23-23 04:05PM
May-16-23 12:00PM
May-15-23 04:45PM
May-12-23 12:00PM
May-09-23 02:00AM
04:05PM Loading…
Apr-17-23 04:05PM
Apr-12-23 12:00PM
Mar-22-23 05:05PM
Mar-06-23 12:00PM
Feb-15-23 04:30PM
Feb-09-23 12:00PM
Jan-09-23 12:00PM
Dec-06-22 12:00PM
Nov-21-22 04:05PM
Oct-13-22 04:05PM
Oct-05-22 12:00PM
Oct-04-22 12:00PM
Sep-12-22 04:05PM
Sep-06-22 04:30PM
01:21PM Loading…
Aug-26-22 01:21PM
Aug-25-22 06:35AM
Aug-24-22 04:05PM
Jul-07-22 12:00PM
Jun-24-22 04:05PM
Jun-03-22 12:00PM
May-24-22 04:05PM
May-17-22 04:05PM
May-13-22 12:00PM
May-12-22 04:05PM
Apr-28-22 04:05PM
Apr-25-22 02:00AM
Apr-06-22 04:05PM
Apr-04-22 01:30AM
Mar-28-22 04:05PM
Mar-11-22 05:18PM
Mar-04-22 12:00PM
Feb-09-22 12:53PM
Feb-08-22 04:05PM
Jan-10-22 12:00PM
Jan-03-22 04:05PM
Dec-14-21 01:30AM
Dec-13-21 04:05PM
Dec-10-21 12:00PM
Dec-01-21 09:22AM
Nov-29-21 04:05PM
Nov-15-21 04:05PM
Nov-10-21 01:30AM
Nov-09-21 02:00AM
Nov-05-21 01:21PM
Oct-25-21 12:11PM
Oct-07-21 12:00PM
Oct-04-21 04:05PM
Sep-28-21 04:05PM
Sep-22-21 12:30PM
Sep-20-21 04:05PM
Sep-15-21 04:05PM
Sep-06-21 04:05PM
Sep-03-21 12:00PM
Aug-30-21 04:05PM
Aug-24-21 04:30PM
Aug-05-21 12:00PM
Jul-30-21 08:50AM
Jul-29-21 04:05PM
Jul-27-21 01:30AM
Jul-21-21 04:05PM
Jul-06-21 12:00PM
Jun-25-21 04:30PM
Jun-07-21 12:00PM
May-26-21 04:30PM
May-25-21 04:00PM
May-07-21 12:00PM
May-04-21 04:30PM
Apr-29-21 02:30AM
Apr-28-21 07:30PM
Apr-20-21 01:30AM
Apr-19-21 01:30AM
Apr-07-21 04:30PM
Mar-09-21 04:30PM
Mar-08-21 04:30PM
Mar-05-21 12:00PM
Mar-04-21 04:30PM
Phaxiam Therapeutics SA is a biopharmaceutical company, which develops red blood cell-based therapeutics for severe forms of cancer and orphan diseases. It operates through the following technical platforms: ERYCAPS, ERYCEV and ERYTECH. The ERYCAPS which uses a novel technology to encapsulate drug substances inside red blood cells. The ERYCEV focuses on potential of drug-loaded extracellular vesicles, derived from red blood cells. ERYTECH developing product candidates for patients with unmet medical needs. The company was founded in 2004 and is headquartered in Lyon, France.